ADMA BIOLOGICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Adma Biologics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Adma Biologics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 236M shares, a 4.61% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 236M +10.4M +4.61% Nov 1, 2024 10-Q 2024-11-07
Q2 2024 233M +8.18M +3.64% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 232M +9.65M +4.35% May 3, 2024 10-Q 2024-05-09
Q3 2023 226M +29.2M +14.8% Nov 3, 2023 10-Q 2023-11-08
Q2 2023 225M +28.5M +14.5% Aug 4, 2023 10-Q 2023-08-09
Q1 2023 222M +26.2M +13.4% Mar 17, 2023 10-K 2023-03-23
Q3 2022 197M +963K +0.49% Nov 4, 2022 10-Q 2022-11-09
Q2 2022 196M +63.6M +47.9% Aug 5, 2022 10-Q 2022-08-10
Q1 2022 196M +74.6M +61.6% Mar 18, 2022 10-K 2022-03-24
Q3 2021 196M +101M +107% Nov 5, 2021 10-Q 2021-11-10
Q2 2021 133M +46.4M +53.8% Aug 6, 2021 10-Q 2021-08-11
Q1 2021 121M +34.9M +40.5% Mar 16, 2021 10-K 2021-03-25
Q3 2020 94.5M +35.2M +59.4% Nov 2, 2020 10-Q 2020-11-05
Q2 2020 86.3M +27M +45.6% Aug 3, 2020 10-Q 2020-08-05
Q1 2020 86.3M +40M +86.3% Mar 10, 2020 10-K 2020-03-13
Q3 2019 59.3M +13M +28% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 59.3M +13M +28% Aug 6, 2019 10-Q 2019-08-08
Q1 2019 46.4M +1.04M +2.29% Mar 11, 2019 10-K 2019-03-13
Q3 2018 46.4M +20.6M +79.7% Nov 5, 2018 10-Q 2018-11-09
Q2 2018 46.3M +20.6M +79.7% Aug 10, 2018 10-Q 2018-08-10
Q1 2018 45.3M +32.4M +252% Mar 9, 2018 10-K 2018-03-29
Q3 2017 25.8M +12.9M +100% Nov 1, 2017 10-Q 2017-11-03
Q2 2017 25.8M +12.9M +100% Aug 11, 2017 10-Q 2017-08-11
Q1 2017 12.9M +2.17M +20.3% Feb 24, 2017 10-K 2017-02-24
Q3 2016 12.9M +2.17M +20.3% Nov 10, 2016 10-Q 2016-11-10
Q2 2016 12.9M +2.18M +20.4% Aug 12, 2016 10-Q 2016-08-12
Q1 2016 10.7M +1.42M +15.3% Mar 23, 2016 10-K 2016-03-23
Q3 2015 10.7M +1.42M +15.3% Nov 10, 2015 10-Q 2015-11-10
Q2 2015 10.7M +1.41M +15.2% Aug 10, 2015 10-Q 2015-08-11
Q1 2015 9.29M 0 0% Mar 6, 2015 10-K 2015-03-09
Q3 2014 9.29M +67.9K +0.74% Nov 7, 2014 10-Q 2014-11-10
Q2 2014 9.29M +3.42M +58.3% Aug 11, 2014 10-Q 2014-08-11
Q1 2014 9.29M +4.67M +101% Mar 28, 2014 10-K 2014-03-28
Q3 2013 9.22M +4.6M +99.5% Nov 12, 2013 10-Q 2013-11-12
Q2 2013 5.87M +1.22M +26.1% Aug 12, 2013 10-Q 2013-08-12
Q1 2013 4.62M -31.5K -0.68% Mar 5, 2013 10-K 2013-03-06
Q3 2012 4.62M +2.12M +84.9% Nov 12, 2012 10-Q 2012-11-13
Q2 2012 4.65M Aug 13, 2012 10-Q 2012-08-14
Q1 2012 4.65M May 14, 2012 10-Q 2012-05-15
Q4 2011 2.5M Jan 31, 2012 10-Q 2012-02-01
Q3 2011 2.5M Oct 28, 2011 10-Q 2011-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.